Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-063100
Filing Date
2025-06-26
Accepted
2025-06-26 17:19:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5907
  Complete submission text file 0001104659-25-063100.txt   7676
Mailing Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623
Business Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623 213-273-5453
Liminatus Pharma, Inc. (Subject) CIK: 0001971387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-95001 | Film No.: 251081376
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 8, CHEOMDAN 1-RO JEONGUP-SI JEONLABUK-DO M5 320836
Business Address 8, CHEOMDAN 1-RO JEONGUP-SI JEONLABUK-DO M5 320836 82 10 8765 6137
Ewon Comfortech Co., Ltd. (Filed by) CIK: 0001973072 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G